Assyro AI

Orange Book product · Generic (ANDA)

CYCLACILLIN

CYCLACILLIN

Generic (ANDA)ANDA 062895DISCN TEVA

At a glance

Aug 04, 1988

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Aug 04, 1988

    38 yr 5 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

CYCLACILLIN

Strength

250MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 062895

Product number

001

Marketing status

DISCN

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of CYCLACILLIN

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.